Virtual International Conference forAdvances in Therapies and Prevention of Alzheimer’s and Related Disorders

2022-07-15

 

Aug 13Sat, 2022                                                                                      Plenary Session

Time

Theme Speaker

Title of Presentatio

Host

09:00-09:02

Mrs.Peiyun Peng

honorary president of CAAD

Opening Remarks

Jun Wang

09:02-09:04

National Health Commission of P.R.China

Opening Remarks

Jun Wan

09:04-09:05

Dr. Jun Wang

President of CAAD

Opening Remarks

Hongzheng Wang

09:05-09:35

Dr. Virginia Lee

USA Academician

Univ. of Pennsylvania

Tau Strains Determine Disease-Specific Cell Type Vulnerability 

Jun Wang

09:35-10:05

Dr. Jeffrey Cummings

University of Nevada, Las Vegas, USA

Alzheimer’s Disease Drug Development: New Treatments and New Challenges

Jun Wang

10:05-10:35

Dr. Martin Prince

King's College London, UK, 

Founder of ADI-1066

Public health approaches and implementation of dementia care

Shengdi Chen

10:35-11:05

Dr. Joseph El Khoury

Harvard University, USA

Study on microglia in the pathogenesis of AD

Yong Ji

11:05-11:35

Dr. Chuanhai Cao

USF college of pharmacy, USA

Association between Alzheimer's disease and a novel coronavirus pneumoni

Kuncheng Li





11:35-12:05

Dr. Changiz Geula

Northwestern University

Northwestern SuperAging Project: Investigation of Elderly with Exceptional Cognitive Performance

Yong Ji

12:05-13:30

Lunch Break

13:30-13:55

Dr. Shumin Duan

Academician

Zhejiang University

Understanding brain science with a focus on brain health

Yanjiang Wang

13:55-14:20

Dr. Charlotte L. Clarke

Faculty of Social Science & Health, Durham University, UK

Helping caregivers to care – an integrated approach

Yanjiang Wang

14:20-14:45

Kang YU

Peking Union Medical College Hospital

Nutritional Management for Patients with Cognitive Impairment

Hongzheng Wang

14:45-15:10

Prof. Gong Chen

Institute of nerve regeneration, 

Jinan University

Applications of neuroregenerative gene therapy in the treatment of 

Alzheimer’s disease

Biao Chen

15:10-15:35

Prof. Meiyu Geng

 Shanghai Institute of Materia Medica, Chinese Academy of Sciences

A pilot study on the basis of gv-971-gut microbiota disturbance and neuro-inflammatory diseases as an original AD

 treatment in China

Hongzheng Wang

15:35-16:00

Feng Gao

The First Affiliated Hospital of USTC, Institute on Aging and Brain Disorders

The blood biomarkers for Alzheimer’s disease clinical diagnosis.

Shengdi Chen

16:00-16:25

Chunyan Liu

Xuanwu Hospital  Capital 

Medical University

Modulating Brain Oscillations Promotes Brain Connectivity to Improve 

Cognitive Impairment

Kuncheng Li

Host's closing speech


 
【关闭窗口】

Address: 1007, 1 Kunsha Center, 16 Xinyuanli, Chaoyang District, Beijing, PRC 100027

Tel:86-10-8411 0913

Email: caadoffice@163.com , caadconference@163.com

Website:http://www.caad.org.cn/col/col375/index.html

Produced By 澶ф眽缃戠粶 澶ф眽鐗堥�氬彂甯冪郴缁�